| Market revenue in 2025 | USD 27,358.3 million |
| Market revenue in 2033 | USD 68,608.5 million |
| Growth rate | 12.27% (CAGR from 2026 to 2033) |
| Largest segment | Oncology testing |
| Fastest growing segment | Genetic Testing |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Disease Testing, Endocrinology Testing, Neurology Testing, Oncology Testing, Toxicology Testing, Genetic Testing |
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| OPKO Health Inc | View profile | 3,930 | 4400 Biscayne Boulevard, Miami, FL, United States, 33137 | www.opko.com |
| ARUP Laboratories | View profile | 1001-5000 | Salt Lake City, Utah, United States, North America | www.aruplab.com |
| H U Group Holdings Inc | View profile | 11,561 | Shinjuku Mitsui Building, 2-1-1 Nishishinjuku, Shinjuku-ku, Tokyo, Japan, 163-0408 | www.hugp.com |
| Athenahealth | View profile | 5001-10000 | Watertown, Massachusetts, United States, North America | www.athenahealth.com |
| Sonic Healthcare Ltd | View profile | 41,000 | 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, Australia, 2000 | www.sonichealthcare.com |
| Healius Ltd | View profile | 10,500 | 161 Castlereagh Street, Level 22, Sydney, NSW, Australia, 2000 | www.healius.com.au |
| Stanford Health Care | View profile | 10001+ | Palo Alto, California, United States, North America | stanfordhealthcare.org/ |
| the mayo foundation | View profile | - | - | - |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Esoteric Testing Market Outlook will help companies and investors design strategic landscapes.
Oncology Testing was the largest segment with a revenue share of 31.24% in 2025.
Horizon Databook has segmented the Global esoteric testing market based on infectious disease testing, endocrinology testing, neurology testing, oncology testing, toxicology testing, genetic testing covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of global-level data and insights on the Global Esoteric Testing Market, including forecasts for subscribers. This global databook contains high-level insights into Global Esoteric Testing Market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
